Mol Divers
(400 MHz, DMSO) 10.96 (s, 1H, NH), 8.12 (s, 1H, Ar),
168.64 (NHC=O), 158.08 (q, J = 32.8 Hz, CF –C=O),
δ
δ
3
7.74 (d, J = 8.0 Hz, 1H, Ar), 7.58 (m, 1H, Ar), 7.74 (d,
J = 7.6 Hz, 1H, Ar), 5.42 (d, J = 2.4 Hz, 1H, 2-H), 4.64–
4.68 (m, 1H, 4-H), 4.45 (br, 1H, OH), 3.65–3.77 (m, 2H,
5-H), 1.97–2.29 (m, 2H, 3-H) ppm. 13C NMR (100 MHz,
DMSO-d ) 169.09 (NHC=O), 159.65 (d, J = 32.3 Hz,
135.25, 128.93 (2C, Ar), 128.67, 122.60 (2C, Ar), 114.58
(q, J = 285.7 Hz, CF3–C=O), 68.91, 60.52, 55.74, 37.12
ppm. Anal. Calcd for C13H12ClF3N2O3: C, 46.37; H, 3.59;
N, 8.32; Found: C, 46.30; H, 3.54; N, 8.27%.
δ
6
CF3–C=O), 139.38, 130.10, 129.80 (q, J = 32.1 Hz, C–
CF3), 125.36 (q, J = 282.3 Hz, Ar–CF3), 122.64, 119.90
(q, J = 4.3 Hz, CH–Ar), 115.43 (q, J = 287.6 Hz, CF3–
C=O), 68.94, 60.54, 55.76, 37.10 ppm. Anal. Calcd for
C14H12F6N2O3: C, 45.42; H, 3.27; N, 7.57. Found: C, 45.40;
H, 3.26; N, 7.55%.
(2R,4S)-N-(2-bromo-4-chlorophenyl)-4-hydroxy-1-(2,2,2-
trifluoroacetyl)pyrrolidine-2-carboxamide (3h) White solid
◦
25
◦
α
(360 mg, 87% yield): Mp 231–236 C; [ ]D = +1.0
(c 0.20, MeOH);IR (KBr, cm−1) 3491, 3274, 3027, 1682,
1584, 1572, 1526.1H NMR (400 MHz, DMSO) 9.95 (s,
δ
1H, NH), 7.83 (m, 1H, Ar), 7.53–7.55 (m, 1H, Ar), 7.46–
7.49 (m, 1H, Ar), 5.38 (d, J = 3.2 Hz, 1H, 2-H), 4.79 (m,
1H, 4-H), 4.45 (br, 1H, OH), 3.63–3.77 (m, 2H, 5-H), 2.00–
2.31 (m, 2H, 3-H) ppm. 13C NMR (100 MHz, DMSO-d6)
169.02 (NHC=O), 154.63 (q, J = 37.2 Hz, CF –C=O),
(2R,4S)-4-hydroxy-N-(4-nitrophenyl)-1-(2,2,2-trifluoroac-
etyl)pyrrolidine-2-carboxamide (3e) Brown solid (253 mg,
◦
25
◦
α
73% yield): Mp 250–255 C; [ ]D = +0.45 (c 0.10,
MeOH); IR (KBr, cm−1) 3497, 3283, 1681, 1614, 1597,
1555. H NMR (400 MHz, DMSO) 10.93 (s, 1H, NH),
δ
3
134.85, 131.88, 130.37, 128.34, 128.07, 118.75, 115.99 (q,
J = 287.7 Hz, CF3–C=O), 68.89, 60.08, 55.65, 37.09 ppm.
Anal. Calcd for C13H11BrClF3N2O3: C, 37.57; H, 2.67; N,
6.74; Found: C, 37.53; H, 2.62; N, 6.70%.
1
δ
8.24 (d, J = 9.2 Hz, 2H, Ar), 7.84 (d, J = 8.8 Hz, 2H,
Ar), 5.43 (d, J = 3.2 Hz, 1H, 2-H), 4.58–4.72 (m, 1H,
4-H), 4.46 (br, 1H, OH), 3.66–3.79 (m, 2H, 5-H), 1.98–
2.31 (m, 2H, 3-H) ppm. 13C NMR (100 MHz, DMSO-d6)
169.43(NHC=O), 154.68 (q, J = 36.4 Hz, CF –C=O),
δ
3
(2R,4S)-N-(4-fluoro-3-nitrophenyl)-4-hydroxy-1-(2,2,2-tri-
144.71, 142.41, 125.02, 118.93, 115.94 (q, J = 287.7 Hz,
CF3–C=O), 68.98, 60.63, 55.77, 37.06 ppm. Anal. Calcd
for C13H12F3N3O5: C, 44.96; H, 3.48; N, 12.10; Found: C,
44.93; H, 3.45; N, 12.12%.
fluoroacetyl)pyrrolidine-2-carboxamide (3i) Cream solid
◦
25
(281mg, 77% yield): Mp 201–205 C; [ ]D = +1.35◦ (c
α
0.10, MeOH); IR (KBr, cm−1) 3484, 3272, 3066, 1676, 1626,
1
1544, 1499. H NMR (400 MHz, DMSO) 10.90 (s, 1H,
δ
NH), 7.82–8.36 (m, 3H, Ar), 5.43 (m, 1H, H-2), 4.65 (m, 1H,
4-H), 4.46 (br, 1H, OH), 3.65–3.78 (m, 2H, 5-H), 2.04–2.31
(m, 2H, 3-H) ppm. 13C NMR (100MHz, DMSO-d ) 169.56
(NHC=O), 159.45 (d, J = 32.0 Hz, CF3–C=O), 150.95 (d,
J = 246.8 Hz, CF–Ar), 140.41, 135.66 (d, J = 21.0 Hz,
C–NO2–Ar), 121.15 (d, J = 8.0 Hz, C–Ar), 118.81 (d,
J = 21.0 Hz, C–Ar), 116.48 (d, J = 8.5 Hz, C–Ar), 115.27
(q, J = 285.0 Hz, CF3–C=O), 68.94, 60.61, 55.74, 37.00
ppm. Anal. Calcd for C13H11F4N3O5: C, 42.75; H, 3.04; N,
11.50; Found: C, 42.70; H, 3.00; N, 11.43%.
(2R,4S)-N-(2,5-difluorophenyl)-4-hydroxy-1-(2,2,2-trifluo-
roacetyl)pyrrolidine-2-carbo◦xamide (3f) White solid (310
δ
6
25
mg, 92% yield): Mp 168 C; [ ]D = +2.0◦ (c 0.10,
α
MeOH); IR (KBr, cm−1) 3494, 3280, 3060, 1678, 1631,
1541.1H NMR (400 MHz, DMSO) 10.34 (s, 1H, NH), 7.89
δ
(m, 1H, Ar), 7.35 (m, 1H, Ar), 7.00 (m, 1H, Ar), 5.38 (br, 1H,
2-H), 4.89 (m, 1H, 4-H), 4.44 (br, 1H, OH), 3.64–3.73 (m,
2H, 5-H), 1.96–2.30 (m, 2H, 3-H) ppm. 13C NMR (100 MHz,
DMSO-d ) 169.57 (NHC=O), 159.09 (d, J = 35.7 Hz,
δ
6
CF3–C=O), 157.75 (d, J = 238.8 Hz, C–F (meta)), 149.08
(d, J = 242.2 Hz, C–F (orto)), 126.99 (d, J = 25.0 Hz,
C–Ar), 116.43 (dd, J = 21.9, 10.0 Hz, C–Ar), 115.98 (q,
J = 287.7 Hz, CF3–C=O), 110.93 (dd, J = 24.5, 8.3 Hz,
C–Ar), 109.48 (dd, J = 29.8, 11.6 Hz, C–Ar), 68.95, 60.15,
55.72, 37.13 ppm. Anal. Calcd for C13H11F5N2O3: C, 46.16;
H, 3.28; N, 8.28; Found: C, 46.11; H, 3.23; N, 8.21%.
(2R,4S)-N-(3,5-bis(trifluoromethyl)phenyl)-4-hydroxy-1-(2,
2,2-trifluoroacetyl)pyrrolidine-2-carboxamide (3j) Pink so-
◦
25
lid (306 mg, 70% yield): Mp 250 C; [ ]D = +0.81◦ (c
α
0.10, MeOH); IR (KBr, cm−1) 3490, 3277, 3089, 1675, 1556,
1474. H NMR (400 MHz, DMSO) 10.80 (s, 1H, NH),
1
δ
8.53–8.54 (m, 1H, Ar), 7.84–7.86 (m, 1H, Ar), 7.55–7.60
(m, 1H, Ar), 5.42 (d, J = 3.6 Hz, 1H, H-2), 4.64 (m, 1H,
4-H), 4.46 (br, 1H, OH), 3.65–3.78 (m, 2H, 5-H), 1.98–2.30
(m, 2H, 3-H)ppm. 13C NMR(100MHz, DMSO-d ) 169.10
(NHC=O), 158.54 (q, J = 31.5 Hz, CF3–C=O), 137.96 (d,
J = 1.9 Hz), 132.65, 123.56, 123.50 (q, J = 268.1 Hz,
CF3), 116.89, 115.37 (q, J = 268.0 Hz, CF3–C=O), 68.94,
60.52, 55.75, 37.07 ppm. Anal. Calcd for C15H11F9N2O3: C,
41.11; H, 2.53; N, 6.39; Found: C, 41.08; H, 2.50; N, 6.35%.
(2R,4S)-N-(4-chlorophenyl)-4-hydroxy-1-(2,2,2-trifluoroa-
cetyl)pyrrolidine-2-car◦boxamide (3g) Cream solid (279 mg,
25
83% yield): Mp 86–90 C; [ ]D = +3.52◦ (c 0.20, MeOH);
α
δ
6
IR (KBr, cm−1) 3492, 3298, 30148, 1680, 1615, 1535.
1H NMR (400 MHz, DMSO) 10.44 (s, 1H, NH), 7.37–
δ
7.73 (m, 4H, Ar), 5.63 (d, J = 4.8Hz, 1H, 2-H), 4.64 (m,
1H, 4-H), 4.44 (br, 1H, OH), 3.64–3.76 (m, 2H, 5-H), 1.99–
2.01 (m, 2H, 3-H) ppm. 13C NMR (100 MHz, DMSO-d6)
123